QualityStocksNewsBreaks Archives - Page 409 of 1476

TuesdayNov 01, 2022 12:56 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be participating in the 5th annual Neuropsychiatric & Psychedelics Drug Development Summit. The summit runs through Nov. 2, 2022, and is being held in Boston. Cybin director of neuropharmacology Amy Reichelt, PhD, will present during the event; her presentation, titled “CYB004 — Modifications to DMT to Enhance its Therapeutic Potential,” includes an overview of the preclinical data for CYB004, Cybin’s deuterated dimethyltryptamine (DMT) program and the advantages of deuteration on its therapeutic effect. Reichelt’s presentation will begin at 1:15 p.m. ET today.“I am delighted to be…

TuesdayNov 01, 2022 12:33 pm

QualityStocksNewsBreaks – Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) Engages IMS for Investor Communications Expertise

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean technology company developing transformative power conversion technologies and control system solutions for next-generation electrical systems, today announced that it has retained IMS Investor Relations (“IMS”) effective Oct. 1, 2022. According to the update, IMS will provide capital markets consulting, corporate communications and strategic investor outreach. “Hillcrest’s highly adaptive power conversion technology is at an exciting stage of growth and development, evidenced in part by our two recent strategic partnerships including a global tier 1 automotive supplier,” said Hillcrest Chief Executive Officer Don Currie. “IMS is a respected firm with proven sector experience, and…

TuesdayNov 01, 2022 10:41 am

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device

Odyssey Health (OTC: ODYY) has filed for United States and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device (“Nasal Device”). As previously announced, Odyssey’s recently completed phase I study to treat concussion successfully used Odyssey’s Nasal Device and drug combination. “We were very pleased with the functionality and performance of the Nasal Device during the phase I study and its administration of Odyssey’s PRV-002 concussion drug,” said Michael Redmond, CEO of Odyssey. “The ability to get drugs for neurological conditions delivered directly into the brain rapidly at effective levels while simultaneously having less concern for side effects…

MondayOct 31, 2022 1:51 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Shows Superior Performance to Other Anthracyclines, Standards of Care for GBM

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical innovator staking out its own position within the competitive field of research, having already progressed to human trials evaluating its novel glioblastoma multiforme (“GBM”) solution, known as Berubicin (or WP744). “Berubicin is a patented doxorubicin (‘Dox’) analog – an anthracycline chemotherapy agent novel in its ability to cross the blood-brain barrier to target tumors directly. Tested against Dox in cancer cells, Berubicin showed a greater capacity to destroy or damage the cancers. In models evaluating intracranial gliomas, Berubicin showed a greater capacity to prolong life than temozolomide, another standard of care for GBM,”…

MondayOct 31, 2022 1:37 pm

QualityStocksNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Secures LOI for up to $100M to Help Fund next Stage of Growth

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance lidar solutions, has rapidly emerged as a leader amongst its peers – deploying its unique capabilities across a host of different environments, ranging from traffic systems in Cape Town, South Africa, to airport terminal monitoring in the U.S. “Cepton’s long-term automotive Tier 1 partner, Koito Manufacturing Co. Ltd., recently revealed that it had provided Cepton with a letter of intent representing an investment of up to $100 million to help fund Cepton’s next stage of growth as it seeks to scale its lidar solutions for mass deployment,” a recent…

MondayOct 31, 2022 1:23 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Filling Talent Gap, Helping Companies Meet ESG Goals

Correlate Infrastructure Partners (OTCQB: CIPI) is a driver of highly cost-effective solutions for energy use optimization. “Environmental, Social and Governance (‘ESG’) goals are becoming more integral in corporate America, with many players looking to preserve precious resources and slash their carbon emissions. In addition, the growing number of environmental regulations in the country is prompting companies to realign their operations and explore new ways to meet the current standards. This shift has triggered resource-intensive efforts, including electrifying older buildings and, according to Marta Schantz, the co-executive director of Urban Land Institute, looking for talent with the right analytics experience and…

MondayOct 31, 2022 1:14 pm

QualityStocksNewsBreaks — GeoSolar Technologies Inc.’s Renewable Energy and All-Home Solution Providing Resilience to Extreme Weather Events

GeoSolar Technologies offers an end-to-end solution for building new homes or retrofitting existing homes with leading energy-efficient technologies. “Devastating weather events like Hurricane Ian regularly leave millions of people throughout the path of the storm without power. In fact, weather is nearly always responsible for major power outages, the culprit in 83% of the cases between 2000 and 2021, according to Climate Central. This begs the question of what can be done to help develop resilience. An answer: renewable energy and all-home solutions like that of GeoSolar Technologies,” a recent article reads. “The company’s SmartGreen(TM) Home harnesses the power of…

MondayOct 31, 2022 1:11 pm

QualityStocksNewsBreaks – Odyssey Health Inc. (ODYY) Pleased with Safety Profile of Its PRV-002 Concussion Treatment

Odyssey Health (OTC: ODYY) recently announced the completion of the second Cohort of its Phase I Multi-Day Ascending Dosing (“MAD”) clinical trial. “Odyssey’s trial involved administering its novel drug to treat concussions, PRV-002, to healthy human subjects to determine drug safety. A total of 40 healthy subjects took part in the study. In Cohort I, eight patients received a low dose of the drug, and in Cohort II, patients received a high dose of the drug. The second Cohort reflected the success of the first, where the drug was well tolerated and proved safe with no severe adverse events reported,”…

MondayOct 31, 2022 10:16 am

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Responses from Participants of Its Strikingly Different FIVE EV Crossover Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, is seeing an overwhelmingly positive response to its Strikingly Different FIVE EV Crossover tour. Tour participants, including potential buyers and Mullen investors, who reserve a spot on the tour are enjoying the opportunity to ride the Mullen EV Crossover and personally interact with Mullen’s updated infotainment system, which features PERSONA, Mullen’s proprietary Personal Vehicle Assistant technology. PERSONA uses the latest facial recognition technology, which enables the vehicle to provide a highly personalized experience to every driver of the Mullen FIVE. The tour kicked off in Pasadena, California, last week, and has…

FridayOct 28, 2022 3:30 pm

QualityStocksNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Ideally Positioned as Cybersecurity Industry Surges

Cerberus Sentinel (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona, is poised to profit as the cybersecurity industry prepares for rapid growth. A recent Cybersecurity Report published by McKinsey & Company highlighted this forecasted rise, citing a new survey revealing a $2 trillion market opportunity for cybersecurity technology and service providers. The publication reads, “In the face of this cyber onslaught, organizations around the world spent around $150 billion in 2021 on cybersecurity, growing by 12.4 percent annually. However, set against the scale of the problem, even this ‘security awakening’ is probably…

Site Search

Company Search

Category: QualityStocksNewsBreaks